UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

Scientific reports, 2024-02, Vol.14 (1), p.3129-3129, Article 3129

2024

Volltextzugriff (PDF)

Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women

Cochrane database of systematic reviews, 2017-05, Vol.2017 (5)

2017

Volltextzugriff (PDF)

Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions

Cancer, 2007-08, Vol.110 (3), p.590-598

2007

Volltextzugriff (PDF)

Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study

Current oncology (Toronto), 2024-02, Vol.31 (3), p.1278-1290

2024

Volltextzugriff (PDF)

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer

Breast cancer research : BCR, 2017-05, Vol.19 (1), p.54-8, Article 54

2017

Volltextzugriff (PDF)

The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience

Journal of kidney cancer and VHL, 2024-01, Vol.11 (1), p.41-48

2024

Volltextzugriff (PDF)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer

Journal of bone oncology, 2021-02, Vol.26, p.100343-100343, Article 100343

2021

Volltextzugriff (PDF)

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy

Clinical chemistry (Baltimore, Md.), 2013-01, Vol.59 (1), p.327-329

2013

Volltextzugriff (PDF)

Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis

Cancer treatment reviews, 2020-11, Vol.90, p.102086, Article 102086

2020

Volltextzugriff (PDF)

Revisiting the Association Between Endometriosis and Bipolar Disorder

Journal of obstetrics and gynaecology Canada, 2011-11, Vol.33 (11), p.1141-1145

2011

Volltextzugriff (PDF)

Comparative overall survival of patients in trials of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1056-1056

2023

Volltextzugriff (PDF)

Comparison of treatment-related adverse events (TRAE) of different CDK4/6 inhibitors (CDK4/6i) in metastatic breast cancer (MBC): A network meta-analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13052-e13052

2020

Volltextzugriff (PDF)

The survival outcomes of metastatic non-clear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre (PMCC) experience

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.636-636

2023

Volltextzugriff (PDF)

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

Breast cancer research and treatment, 2024-07

2024

Volltextzugriff (PDF)

A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.115-115

2023

Volltextzugriff (PDF)

Is there a role for surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC)?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5092-5092

2022

Volltextzugriff (PDF)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-01-01-OT1-01-01

2022

Volltextzugriff (PDF)

Evaluating the impact of bone-targeted agents in the era of novel androgen targeted therapy for metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16500-e16500

2017

Volltextzugriff (PDF)

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Current oncology (Toronto), 2024-08, Vol.31 (8), p.4531-4545

2024

Volltextzugriff (PDF)

Abstract P3-07-14: A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-07-14

2023

Volltextzugriff (PDF)

Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions

Applied physiology, nutrition, and metabolism, 2009-04, Vol.34 (2), p.197

2009

Volltextzugriff (PDF)

A phase Ib study of an anti-HER2 inhibitor, lapatinib, in combination with a c-MET and VEGFR inhibitor, foretinib, in HER2-positive metastatic breast cancer (MBC): Results from NCIC CTG IND.198

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.518-518

2013

Volltextzugriff (PDF)

NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5042-5042

2013

Volltextzugriff (PDF)

Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based Study

JAMA oncology, 2015-12, Vol.1 (9), p.1238

2015

Volltextzugriff (PDF)

Rottlerin dissolves pre-formed protein amyloid: A study on hen egg white lysozyme

Biochimica et biophysica acta, 2011-09, Vol.1810 (9), p.809-814

2011

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women

Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions

Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer

The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy

Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis

Revisiting the Association Between Endometriosis and Bipolar Disorder

Comparative overall survival of patients in trials of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

Comparison of treatment-related adverse events (TRAE) of different CDK4/6 inhibitors (CDK4/6i) in metastatic breast cancer (MBC): A network meta-analysis

The survival outcomes of metastatic non-clear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre (PMCC) experience

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future

Is there a role for surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC)?

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Evaluating the impact of bone-targeted agents in the era of novel androgen targeted therapy for metastatic castration-resistant prostate cancer

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Abstract P3-07-14: A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237

Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions

A phase Ib study of an anti-HER2 inhibitor, lapatinib, in combination with a c-MET and VEGFR inhibitor, foretinib, in HER2-positive metastatic breast cancer (MBC): Results from NCIC CTG IND.198

NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC)

Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based Study

Rottlerin dissolves pre-formed protein amyloid: A study on hen egg white lysozyme

Suchergebnisse filtern